Document is current
Any future updates will be listed below
-
Authors
Haug, Severin
Wenger, Andreas
Arana-Arri, Eunate
Barasoain, Maitane
Vélez-Del-Burgo, Ainara
Koutra, Kleio
Molina-Barceló, Ana
De Pablo-Pardo, Teresa
Kiselev, Nikolai
Boumparis, Nikolaos
Studhalter, Olivia
Schaub, Michael P.
Hudders, Liselot
De Keyzer, Eline
Folkvord, Frans
Champion, Katrina
Triantafyllidis, Andreas
,
Segkouli, Sofia
Laloumis, Nikos
Alexiadis, Anastasios
Lithoxoidou, Eirini
Flevarakis, Konstantinos
Spirou, Aggeliki
Georgiadis, Charalabos
Kafetzopoulos, Sotirios
Votis, Konstantinos
Tzovaras, Dimitrios
Kondylakis, Haridimos
Marias, Kostas
Maniadi, Evaggelia
Markakis, Evangelos
Lina, Pelekidou
Tsiknakis, Emmanouil
Papatsaroucha, Dimitra
Kefaloukos, John
Tziraki, Charikleia
Kilintzis, Vassilis
Pityanou, Konstantina
Antivasis, Panagiotis
Katsapi, Chrysoula
Micheli, Katerina
Krini, Maria
Philippou, Nicolas
Pampaka, Theophano
Xydia, Stavri
Ferentinou, Marisa
DeJans, Steffi
Van de Sompel, Dieneke
Beuckels, Emma
Pearce, Hayley
Nicoara, Delia
Nicoara, Niculina
Gavrila, Iulia
Maghear, Adela
Bogataj, David
Pangrcic, Polonca
Inkret, Anja
Goswami, Nandu
Bamidis, Panagiotis
Reppou, Sofia
Tsoupouroglou, Iraklis
Spachos, Dimitrios
Cea, Gloria
Gallego, Alba
Mallo, Irene
Buhid, Eduardo
Fico, Giuseppe
Cabrera, María Fernanda
Villanueva, Francisco Lupianez
Segal, Lucas
Van der Feen, Justine
Dietrich, Nick
Roca-Umbert, Ana
Manso, Marco
Pires, Jose
Guerra, Barbara
Molina, Ana
Vanaclocha, Mercedes
Romeo, Paula
Manyogil, Belen
Gandia, Mireia
del Campo, Laura
Pilotti, Chiara
Valentinotti, Rachele
Iannelli, Elisabetta
De Lorenzo, Francesco
De Persis, Davide
Summa, Alice
Perez, Alvaro Sanchez
Aguirre, María Iciar Astigarraga
Callizo, Enrique Peiro
del Burgo, Ainara Velez
Lago, Janire Orcajo
Martinez, Macarena Debareno
Hernandez, Maitane Barasoain
Arenaza, Izaskun
Liakopoulos, Vassilis
Panagopoulou, Maria
Mavromanolakis, Giorgos
Manteli, Maria
Koulouris, Pavlos
Sotiriou, Sofoklis
Verduyn, Stefanie
Neven, Loes
Rizvi, Katie
Rusu, Oana
Todea, Diana
Cristea, Laura
Trifulescu, Cristina
Boumparis, Niko
Teesson, Maree
Newton, Nicola
-
Funding
Funding for this research was provided by:
Swiss State Secretariat for Education, Research and Innovation (24.000008)
European Union’s Horizon Europe research and innovation program (Grant Agreement Nº 101136829.)
- License Information
-
More Information
Article History
Received: 13 October 2025
Accepted: 20 October 2025
First Online: 24 November 2025
Declarations
:
: The study protocol will be approved by the respective Ethics Committees of all participating countries. As of October, 13 th , 2025, the protocol was approved by the Ethics Committees in all participating countries. For Greece, the protocol was approved by the Hellenic Mediterranean Ethics Committee (approval number 55143; date of approval April 15 th , 2025). For Spain, the protocol was approved by the Ethics Committee for Research involving medicinal products in the Basque Country (approval number PI2024215; date of approval April, 14 th , 2025). For Switzerland, the protocol was approved by the Faculty of Arts and Sciences at the University of Zurich (approval number 25.02.22; date of approval February, 28 th , 2025). For Romania, the protocol was approved by The Oncology Institute "Prof. Dr. Ion Chiricuţă" Cluj-Napoca (approval number 305, date of approval August, 30 th , 2024). For Slovenia, the protocol was approved by the Komisija Republike Slovenije za medicinsko etiko (approval number 0120-282/2025-2711-9; date of approval September 23th, 2025). For Italy, the protocol was approved by the Italian National Ethics Committee for experiments conducted by public research bodies (EPR) and other national public bodies (CEN) at its meeting on September 22 nd , 2025 (Ref. AOO-ISS – 09/29/2025–0039540 Class: PRE BIO CEN 01.00). For Cyprus, the study was approved by the Cyprus National Bioethics Committee with number ΕΕΒΚ ΕΠ 2025.01.278 on 9/9/2025. For Belgium, the study protocol was approved by the Ethics Committee of the Faculty of Politics and Social Science at Gent University (approval number Re 2025-28; date of approval 25 th August, 2025).The trial will be executed in compliance with the Helsinki Declaration. All study participants and their parents/guardians if necessary due to age and national legislation, will provide online informed consent. Data will be collected pseudonymized on a pre-designed electronic Case Report Form (eCRF) through an authoring tool. The rights of participants will be respected, complying with national and EU data protection laws, and any data exchange will be approved by respective national ethical authorities.
: Not applicable.
: The authors declare no competing interests.
